We elected to use two specific mRNA markers mammaglobin-B (MGB-2 and NY-BR-1) highly expressed in breast cancer (Becker et al, 1998; Jager et al, 2001) combined with CK-19. This evidence concerns the gene ANKRD30A and breast carcinoma.